Global Symposium on IGRA's

3rd Global Symposium on IGRAs - Syllabus

Friday, January 13, 2012
8:25	Welcome and Opening Remarks, Antonino Catanzaro, MD and Charles L. Daley, MD
8:30	The New Understanding of the Dynamics of TB Infection, Clifton E. Barry, III, PhD
9:10	What IGRAs Have Allowed Us to Understand About TB, David Lewinsohn, MD, PhD Download the audio from this presentation
9:50	Commentary, Michael D. Iseman, MD Download the audio from this presentation
10:40	What Does the Experience with Immune Modifiers Tell Us About the Mechanism and Risk of Progression to TB Disease, Robert S. Wallis, MD, FIDSA Download the audio from this presentation
11:20	Commentary, Jerold J. Ellner, MD Download the audio from this presentation
1:30	Do IGRAs Identify Persons Who Are Likely Not to Progress to Active TB, Albert Nienhaus, MD, PhD Download the audio from this presentation
2:10	How Well Do IGRAs Perform the Identification of Persons Who Are Likely to Progress to Active TB, Pranab Haldar, MD, MRCP Download the audio from this presentation
3:10	Predictive Value of IGRAs for Progression to Active Tuberculosis in HIV 1 Infected Women, S. Jonnalagadda Download the audio from this presentation
3:25	Predictive Value of IGRAs for Progression to Active Tuberculosis in TB Contacts in Singapore, C. Chee Download the audio from this presentation
3:40	Predictive Value of IGRAs for Progression to Active Tuberculosis in Children: Results of a Longitudinal Study in Germany Using IGRAs, Stefanie Castell, MD, MSc Download the audio from this presentation
4:00	Commentary, Ibrahim Abubakar, MD, PhD Download the audio from this presentation
Saturday, January 14, 2012
8:30	Use of IGRAs In the Face of Other Co Morbidities, Luca Richeldi, MD, PhD Download the audio from this presentation
9:10	Repeated Quantiferon TB Gold in Tube Tests in Routine Clinical Practice: AFive Years Experience, S. Cerr Download the audio from this presentation
9:25	Use of IGRAs in the Face of HIV Immune Modifiers, Pernille Ravn, MD, PhD Download the audio from this presentation
10:05	Screening HIV Infected Patients with IGRAs for LTBI, K. Sakashita Download the audio from this presentation
10:40	Serial Testing with IGRAs in High Risk Populations, R. Garfein Download the audio from this presentation
10:55	Use of IGRAs in the Face of Immune Modifiers, Stephan Gadola, MD, PhD Download the audio from this presentation
11:35	What is the Effect on the IGRA Response By Prednisolone, Tobacco or Inflammatory Bowel Disease? A. Werlinrud Download the audio from this presentation
11:45	Commentary, Neil Schluger, MD Download the audio from this presentation
1:30	IGRA Testing of HCW, Charles L. Daley, MD Download the audio from this presentation
2:10	Active TB in Portuguese HCW, a Descriptive Study, José Castela Torres da Costa Download the audio from this presentation
2:25	IGRAs and Missed Opportunities to Prevent Active Tuberculosis in Healthcare Workers with Positive Tuberculin Skin Tests Attributed to Bacille Calmette Guerin (BCG) Vaccination, J. Katsolis Download the audio from this presentation
2:40	Cost Effectivness and Operating Characteristics of Using Igras in US Healthcare Workers, W. Thanassi Download the audio from this presentation
2:55	Commentary, Renee Ridzon, MD Download the audio from this presentation
3:45	Interpretation of IGRA Results, Edward A. Graviss, PhD, MPH Download the audio from this presentation
4:25	Within Subject Variability of the Quantiferon TB Gold in Tube Assay in a Large Cohort of Low Risk Subjects, J. Metcalfe Download the audio from this presentation
4:40	A Data Based Algorithm for the Clinical Management of Persons with Fluctuations in Serial IGRA Tests to Detect LTBI, D. Marder Download the audio from this presentation
5:00	Commentary, Matthew J. Binnicker, PhD Download the audio from this presentation
Sunday, January 15, 2012
8:30	Dried Plasma Spots in the Diagnosis of TB Infection: IP-10 Release Assay on Filter Paper, M. Ruhwald Download the audio from this presentation
8:45	Pilot Study of Latent Tuberculosis Infection with an Enhanced Elispot Interferon Gamma Release Assay, P. Escalant Download the audio from this presentation
9:00	Cost Effectiveness of IGRAs Versus Chest X Ray for Tuberculosis Screening, A. Kowada Download the audio from this presentation
9:15	Prevalence of LBTI in the General Public in Mazovia and HCW in Poland Using Igras, U. Demkow Download the audio from this presentation
9:30	Screening of HCW and Immigrants with IGRA and TST in Mexico L. Todd, L. Machado, A. Diaz Download the audio from this presentation
9:45	Commentary, Toru Mori, MD, PhD Download the audio from this presentation
10:30	The Use of IGRAs in Children: View From the Laboratory, Beate Hyme, FRCPCH, MD, PhD Download the audio from this presentation
11:30	The Use of IGRAs in Children: View from the Clinic, Jeffrey Starke, MD Download the audio from this presentation
1:30	What Would it Take to Eliminate Tuberculosis by 2050, Laith J. Abu-Raddad, Phd Download the audio from this presentation
2:00	Eliminating TB by 2050, Mario Raviglione, MD Download the audio from this presentation
2:40	Global Applications, Richard O'Brien, MD
2:50	Predictive Value of IGRAs for Progression to Active TB in Children: Results of a longitudinal Study in Germany Using IGRAs, Stefanie Castell, MD, MSc and Roland Diel Download the audio from this presentation
3:40	How Does the Concept of Diagnosing and Treating LTBI Fit Into TB Control in Low, Medium and High Burdon Countries, Edward Nardell, MD Download the audio from this presentation

ucsd

UC San Diego School of Medicine
Continuing Medical Education
2251 San Diego Ave., A-160
San Diego, CA 92110

Phone: (619) 543-7602 • Toll-Free: (888) 229-OCME (6263) • Fax: (619) 543-7610
E-mail: ocme@ucsd.edu • Website: cme.ucsd.edu